Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The goal of this study is to learn about the effect of the study drug acetazolamide in individuals with Type 1 Diabetes. Specifically, whether acetazolamide provides benefits to the kidneys while minimizing any side effects of the drug. These changes will be measured by laboratory tests that tell us how well the kidneys are functioning.
Epistemonikos ID: 4fdb34d705839d4a67ef6704901e34bb88f85296
First added on: May 21, 2025